ANCA-Associated Vasculitis: Practical Issues in Management

被引：2
|
作者：
Roper, Tayeba [1 ]
Salama, Alan David [1 ]
机构：
[1] Royal Free Hosp, UCL Dept Renal Med, London NW3 2PF, England
来源：
INDIAN JOURNAL OF NEPHROLOGY | 2024年 / 34卷 / 01期
关键词：
Anti neutrophil cytoplasm antibody; glucocorticoids; granulomatosis with polyangiitis; microscopic polyangiitis; pathogenesis; treatment; vasculitis; ANTIBODY-ASSOCIATED VASCULITIS; RHEUMATOLOGY CLASSIFICATION CRITERIA; DAILY ORAL CYCLOPHOSPHAMIDE; 2022; AMERICAN-COLLEGE; SYSTEMIC VASCULITIS; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; WEGENERS-GRANULOMATOSIS; RENAL SURVIVAL; RITUXIMAB;
D O I：
10.4103/ijn.ijn_346_23
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
ANCA associated vasculitides are multi-system autoimmune diseases which are increasing in prevalence. In this review we will discuss the clinical manifestations and review the management options. We highlight the various trials of induction and maintenance therapy and discuss the areas of unmet need. These include understanding which patients are at highest risk of relapse, clinical adaptation of improved biomarkers of disease activity and tools to discuss long term prognosis
引用
收藏
页码：6 / 23
页数：18
相关论文
共 50 条
  • [31] Advances in Therapy for ANCA-Associated Vasculitis
    Duvuru Geetha
    Philip Seo
    Current Rheumatology Reports, 2012, 14 : 509 - 515
  • [32] Complications of therapy for ANCA-associated vasculitis
    Smith, Rona
    RHEUMATOLOGY, 2020, 59 : 74 - 78
  • [33] Ocular manifestations of ANCA-associated vasculitis
    Junek, Mats L.
    Zhao, Lily
    Garner, Stephanie
    Cuthbertson, David
    Pagnoux, Christian
    Koening, Curry L.
    Langford, Carol A.
    McAlear, Carol A.
    Monach, Paul A.
    Moreland, Larry W.
    Rhee, Rennie L.
    Seo, Philip
    Specks, Ulrich
    Sreih, Antoine G.
    Warrington, Kenneth
    Wechsler, Michael E.
    Merkel, Peter A.
    Khalidi, Nader A.
    RHEUMATOLOGY, 2023, 62 (07) : 2517 - 2524
  • [34] OPINION Maintenance of clinical remission in ANCA-associated vasculitis
    Luqmani, Raashid
    NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (02) : 127 - 132
  • [35] Evolution of Therapy for ANCA-Associated Vasculitis with Kidney Involvement
    Rajasekaran, Arun
    Rizk, Dana V.
    KIDNEY360, 2023, 4 (12): : 1794 - 1805
  • [36] Addition of Infliximab to Standard Therapy for ANCA-Associated Vasculitis
    Morgan, Matthew D.
    Drayson, Mark T.
    Savage, Caroline O. S.
    Harper, Lorraine
    NEPHRON CLINICAL PRACTICE, 2011, 117 (02): : C89 - C97
  • [37] Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management
    Ge, Shangqing
    Zhu, Xingyu
    Xu, Qinyao
    Wang, Junyan
    An, Cheng
    Hu, Ying
    Yang, Fan
    Wang, Xinyi
    Yang, Yipin
    Chen, Shuwen
    Jin, Ruimin
    Li, Haiyan
    Peng, Xinchen
    Liu, Yue
    Xu, Junnan
    Zhu, Minhui
    Shuai, Zongwen
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [38] Classification of ANCA-Associated Vasculitis
    Khan, Irfan
    Watts, Richard A.
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (12)
  • [39] Biomarkers in ANCA-Associated Vasculitis
    Lally, Lindsay
    Spiera, Robert F.
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (10)
  • [40] Targeted immunotherapy strategies in ANCA-associated vasculitis
    Puechal, Xavier
    JOINT BONE SPINE, 2019, 86 (03) : 321 - 326
12345